Our holdings weather this guilty-until-proven-innocent market. Read More

This pioneer of diabetes treatments has lots of cash, little debt and a $40 billion global market. Read More

An MLP’s ability to outlast the downturn depends on its payout structure. Read More

No more whistling past the graveyard now that durable goods are sliding. Read More

One of my favorite war stories is “The Man Who Never Was,” about a British scheme to deceive the Nazis during World War II by planting misinformation about an upcoming invasion on a corpse made to appear to be a drowned naval officer, the non-existent Royal Marine Major William Martin. Read More

Several measures say much lower, but not for all stocks.  Read More

The agreements are an essential estate-planning tool for older adults who remarry. Read More

Conservative investors in a high tax bracket will love our high-yield muni bond pick. Read More

Low inflation and plunging energy prices leave room for earnings growth if you know where to look. Read More